EYEPOINT PHARMACEUTICALS INC
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About EYPT
EyePoint Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing innovative therapeutics to help improve the lives of patients with serious retinal diseases. The Company’s lead product candidate, DURAVYU, is an investigational sustained delivery treatment for anti-vascular endothelial growth factor (anti-VEGF) mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E. DURAVYU is presently in Phase 3 global, pivotal clinical trials for wet age-related macular degeneration (wet AMD). Additional pipeline programs include EYP-2301, a promising TIE-2 agonist, razuprotafib, formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The Company’s other products include YUTIQ and DEXYCU.
Find out what a historical investment in EYEPOINT PHARMACEUTICALS INC would be worth today using our EYPT stock calculator.
$449.49M
-
0.00%
34
$6.71
$6.45
$0.00
$21.26
$3.91
Ready to start your investing journey with Stake?
Open an accountEYPT FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in EYPT
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in EYPT
on Stake
Buy EYPT from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of EYPT from only US$10 with fractional shares
